Coronary thrombolysis and the new biology.
Sobel
B E
BE
Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri 63110.
D001241:Aspirin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009154:Mutation; D015539:Platelet Activation; D011994:Recombinant Proteins / Q000235:genetics; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000235:genetics*
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator; D001241:Aspirin